Invention Grant
- Patent Title: Cyclopropanecarboxamide modulators of cystic fibrosis transmembrane conductance regulator
-
Application No.: US15539169Application Date: 2015-12-27
-
Publication No.: US10167278B2Publication Date: 2019-01-01
- Inventor: Chengzhi Zhang , Justin Chakma
- Applicant: Auspex Pharmaceuticals, Inc.
- Applicant Address: US CA La Jolla
- Assignee: Auspex Pharmaceuticals, Inc.
- Current Assignee: Auspex Pharmaceuticals, Inc.
- Current Assignee Address: US CA La Jolla
- Agency: Baker & Hostetler LLP
- International Application: PCT/US2015/067544 WO 20151227
- International Announcement: WO2016/109362 WO 20160707
- Main IPC: C07D405/12
- IPC: C07D405/12 ; A61P11/00
Abstract:
The present invention relates to new cyclopropanecarboxamide modulators of cystic fibrosis transmembrane conductance regulator proteins, pharmaceutical compositions thereof, and methods of use thereof.
Public/Granted literature
- US20180265501A1 CYCLOPROPANECARBOXAMIDE MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Public/Granted day:2018-09-20
Information query
